Most people on semaglutide lose about 3.8% of their body weight in the first four weeks and around 15% over 68 weeks. For someone starting at 250 pounds, that translates to roughly 9 to 10 pounds in the first month and about 37 pounds over a year and a half. But the rate isn’t constant. Weight loss starts modestly, accelerates as the dose increases, and eventually levels off around 60 weeks.
What to Expect in the First Month
The first four weeks are a titration period, meaning you start on the lowest dose (0.25 mg per week) to let your body adjust. Even at this small dose, participants in the major clinical trial (known as STEP 1) lost an average of 3.8% of their starting weight. That’s a meaningful early result, though much of it comes from eating less because the medication reduces appetite almost immediately.
Semaglutide slows the rate at which your stomach empties after a meal. In one study of women, food took nearly three hours (171 minutes) to leave the stomach on semaglutide, compared to about two hours (118 minutes) on placebo. That delay means you feel full longer, eat smaller portions, and often lose interest in food between meals. These effects kick in within the first week or two for most people, which is why weight loss begins before you even reach the higher doses.
Months 2 Through 5: The Ramp-Up
The dose increases by 0.25 mg every four weeks, and this gradual climb takes 16 to 20 weeks to reach the full maintenance dose of 2.4 mg. Weight loss accelerates during this period as the appetite-suppressing effect intensifies with each dose increase. The slow titration exists for a practical reason: jumping straight to the full dose causes significant nausea and other gut-related side effects. By building up gradually, most people tolerate the medication well enough to stay on it.
By the time you reach the maintenance dose around month four or five, many people are losing weight at their fastest rate. The exact pace varies, but a steady loss of 1 to 2 pounds per week is typical during this middle stretch. This is the period where the results start to become visually noticeable and where clothing sizes often begin to shift.
The 68-Week Results
The most widely cited data comes from the STEP 1 trial, where participants on semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks (about 16 months). A follow-up trial, STEP 4, found a nearly identical result of 15.2%. The placebo groups in these studies lost only about 2.4%, confirming that the drug itself drives the vast majority of the loss.
These are averages, which means some people lost considerably more and others less. The distribution matters: a significant portion of participants lost 20% or more of their body weight, while others saw only modest changes. The 15% average is not a ceiling for any individual person.
When Weight Loss Slows Down
Weight loss on semaglutide doesn’t continue at the same pace indefinitely. Most people hit a plateau around 60 weeks, roughly 14 months into treatment. At that point, the body has adjusted to its new lower weight through metabolic adaptations. You burn fewer calories at a smaller body size, and the body’s hormonal signals push back against further loss. This plateau is a normal biological response, not a sign the medication has stopped working. It continues to help maintain the weight already lost.
Some people experience smaller plateaus earlier, particularly during the titration phase when the dose hasn’t yet reached its full level. These temporary stalls usually resolve once the next dose increase takes effect.
Why Results Vary Between People
Not everyone responds to semaglutide equally. In one study tracking real-world patients, about 22.5% were classified as non-responders, meaning they lost less than 3% of their weight at three months or less than 5% at six months. That’s roughly one in five people who don’t see clinically meaningful results.
Mental health history appears to play a role. In that same study, nearly half of non-responders had a history of psychiatric illness, and the only three participants who actually gained weight at three months were all women with active major depressive disorder. Depression can interfere with the behavioral changes (eating patterns, activity levels, sleep) that support the medication’s effects. This doesn’t mean people with depression can’t benefit from semaglutide, but it may explain why some individuals see slower or minimal results.
Other factors that influence your personal rate of loss include starting weight (people with more to lose tend to lose faster in absolute pounds), age, sex, metabolic health, and how consistently you take the medication. Dietary habits and physical activity still matter on semaglutide. The drug makes it far easier to eat less, but it doesn’t eliminate the role of food choices and movement.
A Realistic Weight Loss Timeline
- Weeks 1 to 4: About 3 to 4% of body weight, mostly from reduced appetite at the starting dose.
- Weeks 5 to 16: Steady acceleration as the dose increases every four weeks. Most people are losing 1 to 2 pounds per week during this stretch.
- Weeks 17 to 40: The fastest and most consistent period of loss, now at the full 2.4 mg dose. This is where the bulk of total weight loss accumulates.
- Weeks 40 to 60: Weight loss continues but the pace gradually slows as the body adapts.
- Beyond 60 weeks: Most people reach a plateau. The medication’s primary role shifts from driving new loss to maintaining what’s been lost.
These timelines reflect averages from clinical trials. Your personal curve may be faster or slower, and short-term fluctuations from water retention, hormonal cycles, or dietary changes can mask the underlying trend. Tracking weight over weeks and months rather than days gives a much clearer picture of actual progress.